VVUS

VVUS Articles

U.S. equity markets opened higher this morning following an unexpected 0.25% cut in Australia’s key interest rate to a new level of 2.75%. Japan’s Nikkei reopened today after a two-day holiday...
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big...
ThinkstockDrug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the...
ThinkstockVIVUS Inc. (NASDAQ: VVUS) is the king of weight loss drugs now that it is operating with the first pill to help assist weight loss in a decade. The company’s Qsymia recently received an...
ThinkstockBiotech pipeline news and biotech drug news continues to hit. A report from Bank of America/Merrill Lynch is highlighting four small-cap to mid-cap biotech stocks with positive...
ThinkstockVIVUS, Inc. (NASDAQ: VVUS) has just secured Food and Drug Administration  approval of an amendment and modification to the Risk Evaluation and Mitigation Strategy for its weight-loss drug...
Jon OggIt may be the weekend, and the DJIA hit a new high this last week, but there is no such thing as any rest for the wicked. 24/7 Wall St. has identified 13 must-read weekend stock stories for...
U.S. equity markets opened higher this morning but struggled to maintain even a flat performance compared to yesterday’s close. Before the markets opened this morning, the Mortgage Bankers...
Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Agilent Technologies Inc. (NYSE: A) started as Outperform at Leerink...
Investors are always looking for new ideas. Now that the Dow Jones Industrial Average is trying to hit new highs and investors are pouring record inflows of capital into stocks, investors should...
U.S. equity markets opened higher this morning and wobbled around before heading upward for most of the day. Strong home prices and a surge in the consumer confidence index (more coverage here) gave...
ThinkstockVIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug Qsymia. Its...
U.S. equity markets opened higher this morning as they awaited results from the Italian elections. Early exit polls had the center-left party of Pier Luigi Bersani in the lead, but as returns came...
Jon OggThese are some of this Friday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Alcatel-Lucent S.A. (NYSE: ALU) was given positive comments on its new CEO...
ThinkstockIf you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned way through diet, exercise, and...